End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.58 EGP | -8.51% | -10.73% | -17.83% |
Mar. 03 | Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 05 | Ibnsina Pharma(CASE:ISPH) added to EGX 30 Index | CI |
Sales 2024 * | 36.64B 766M | Sales 2025 * | 44.09B 921M | Capitalization | 2.6B 54.35M |
---|---|---|---|---|---|
Net income 2024 * | 417M 8.71M | Net income 2025 * | 417M 8.71M | EV / Sales 2024 * | 0.17 x |
Net Debt 2024 * | 3.65B 76.25M | Net Debt 2025 * | 3.56B 74.44M | EV / Sales 2025 * | 0.14 x |
P/E ratio 2024 * |
8.6
x | P/E ratio 2025 * |
6.7
x | Employees | 5,500 |
Yield 2024 * |
1.51% | Yield 2025 * |
3% | Free-Float | 61.4% |
1 day | -8.51% | ||
1 week | -10.73% | ||
Current month | +7.95% | ||
1 month | -4.09% | ||
3 months | -20.86% | ||
6 months | +21.70% | ||
Current year | -17.83% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 00-12-17 | |
Chief Executive Officer | - | 00-12-17 | |
Momen Gomaa
DFI | Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 00-12-17 | |
Chief Executive Officer | - | 00-12-17 | |
Director/Board Member | - | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 2.58 | -8.51% | 31,964,310 |
24-04-23 | 2.82 | -2.76% | 38,097,040 |
24-04-22 | 2.9 | +5.84% | 13,753,820 |
24-04-21 | 2.74 | +3.01% | 6,052,380 |
24-04-18 | 2.66 | -7.96% | 12,810,700 |
End-of-day quote Egyptian Exchange, April 23, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.83% | 59.16M | |
-31.79% | 15.57B | |
-37.08% | 9.81B | |
+9.74% | 6.08B | |
-10.85% | 6.03B | |
-36.08% | 5.52B | |
-0.73% | 4.75B | |
+52.93% | 4.23B | |
-11.96% | 3.6B | |
-5.92% | 3.16B |
- Stock Market
- Equities
- ISPH Stock